Roger Paredes
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Poxvirus research and outbreaks
- Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 129
- COVID-19 Clinical Research Studies 28
- HIV/AIDS Research and Interventions 20
- SARS-CoV-2 and COVID-19 Research 12
- Virology 41
- HIV Research and Treatment 36
- Co-authors
- Bonaventura Clotet (91 shared papers)Robert W. Shafer (12 shared papers)Annemarie M. J. Wensing (9 shared papers)Vincent Cálvez (9 shared papers)Huldrych F. Günthard (7 shared papers)Marc Noguera-Julián (53 shared papers)Douglas D. Richman (6 shared papers)Eugènia Negredo (23 shared papers)
- Journals
- Clinical Infectious Diseases (24 papers)Journal of Antimicrobial Chemotherapy (21 papers)PLoS ONE (21 papers)AIDS (20 papers)The Journal of Infectious Diseases (17 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Roger Paredes
336 papers receiving 19.8k citations
Roger Paredes's Hit Papers
Peers
Comparison fields: 5 of 142
- Virology 2.6k
- Infectious Diseases 10.1k
- Emergency Medicine 462
- Neurology 281
- Computational Theory and Mathematics 272
Countries citing papers authored by Roger Paredes
This map shows the geographic impact of Roger Paredes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Paredes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Paredes more than expected).
Fields of papers citing papers by Roger Paredes
This network shows the impact of papers produced by Roger Paredes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Paredes. The network helps show where Roger Paredes may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Paredes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 351 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir for the Treatment of Covid-19 — Final Report Hit paper breakdown → | 2020 | 5664 |
| 2 | Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients Hit paper breakdown → | 2021 | 950 |
| 3 | Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study Hit paper breakdown → | 2022 | 531 |
| 4 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 518 |
| 5 | HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects Hit paper breakdown → | 2010 | 469 |
| 6 | 2015 update of the drug resistance mutations in HIV-1 Hit paper breakdown → | 2015 | 384 |
| 7 | Mpox in people with advanced HIV infection: a global case series Hit paper breakdown → | 2023 | 353 |
| 8 | 2016 | 338 | |
| 9 | 2011 | 335 | |
| 10 | Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population Hit paper breakdown → | 2012 | 307 |
| 11 | 2018 | 226 | |
| 12 | 2011 update of the drug resistance mutations in HIV-1. | 2011 | 218 |
| 13 | Update of the drug resistance mutations in HIV-1: March 2013. | 2013 | 215 |
| 14 | 2000 | 211 | |
| 15 | 2000 | 198 | |
| 16 | 2009 | 196 | |
| 17 | 2017 | 193 | |
| 18 | 2000 | 180 | |
| 19 | 2010 | 174 | |
| 20 | 2021 | 160 |
About Roger Paredes
Roger Paredes is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Neurology and Molecular Biology, having authored 351 papers that have together received 20.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (129 papers), HIV Research and Treatment (36 papers), COVID-19 Clinical Research Studies (28 papers), Gut microbiota and health (21 papers), HIV/AIDS Research and Interventions (20 papers), Long-Term Effects of COVID-19 (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and HIV-related health complications and treatments (10 papers). The work is most often cited by research in Virology (2.6k citations), Infectious Diseases (10.1k citations), Emergency Medicine (462 citations), Neurology (281 citations) and Computational Theory and Mathematics (272 citations). Roger Paredes has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Bonaventura Clotet, Robert W. Shafer, Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Marc Noguera-Julián, Douglas D. Richman, Eugènia Negredo, Lı́dia Ruiz and Deenan Pillay. Their work appears in journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, PLoS ONE, AIDS and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.